Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Pharmacogenetically driven treatments for alcoholism: are we there yet?

Arias AJ, Sewell RA.

CNS Drugs. 2012 Jun 1;26(6):461-76. doi: 10.2165/11633180-000000000-00000. Review.

PMID:
22587755
[PubMed - indexed for MEDLINE]
2.

Pharmacogenetics of alcohol and alcohol dependence treatment.

Kranzler HR, Edenberg HJ.

Curr Pharm Des. 2010;16(19):2141-8. Review.

PMID:
20482509
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Personalized treatment of alcohol dependence.

Kranzler HR, McKay JR.

Curr Psychiatry Rep. 2012 Oct;14(5):486-93. doi: 10.1007/s11920-012-0296-5. Review.

PMID:
22810115
[PubMed - indexed for MEDLINE]
4.

The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF.

Alcohol Clin Exp Res. 2012 Mar;36(3):385-94. doi: 10.1111/j.1530-0277.2011.01633.x. Epub 2011 Sep 6. Review.

PMID:
21895723
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.

Goldman D, Oroszi G, O'Malley S, Anton R.

J Stud Alcohol Suppl. 2005 Jul;(15):56-64; discussion 33. Review.

PMID:
16223057
[PubMed - indexed for MEDLINE]
6.

Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone.

Oslin DW, Berrettini WH, O'Brien CP.

Addict Biol. 2006 Sep;11(3-4):397-403. Review.

PMID:
16961767
[PubMed - indexed for MEDLINE]
7.

Identification of molecular targets associated with ethanol toxicity and implications in drug development.

Wang LL, Yang AK, He SM, Liang J, Zhou ZW, Li Y, Zhou SF.

Curr Pharm Des. 2010;16(11):1313-55. Review.

PMID:
20184550
[PubMed - indexed for MEDLINE]
8.

Pharmacogenetic treatments for drug addiction: alcohol and opiates.

Haile CN, Kosten TA, Kosten TR.

Am J Drug Alcohol Abuse. 2008;34(4):355-81. doi: 10.1080/00952990802122564. Review.

PMID:
18584566
[PubMed - indexed for MEDLINE]
9.

The μ-opioid receptor and treatment response to naltrexone.

Thorsell A.

Alcohol Alcohol. 2013 Jul-Aug;48(4):402-8. doi: 10.1093/alcalc/agt030. Epub 2013 Mar 29. Review.

PMID:
23543091
[PubMed - indexed for MEDLINE]
Free Article
10.

Pharmacotherapy of alcohol dependence: a review of the clinical data.

Mann K.

CNS Drugs. 2004;18(8):485-504. Review.

PMID:
15182219
[PubMed - indexed for MEDLINE]
11.

Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone.

Setiawan E, Pihl RO, Benkelfat C, Leyton M.

Pharmacogenomics. 2012 Jul;13(10):1161-72. doi: 10.2217/pgs.12.99. Review.

PMID:
22909206
[PubMed - indexed for MEDLINE]
12.

An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence.

Johnson BA.

Expert Opin Pharmacother. 2004 Sep;5(9):1943-55. Review.

PMID:
15330732
[PubMed - indexed for MEDLINE]
13.

Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis.

Chamorro AJ, Marcos M, Mirón-Canelo JA, Pastor I, González-Sarmiento R, Laso FJ.

Addict Biol. 2012 May;17(3):505-12. doi: 10.1111/j.1369-1600.2012.00442.x. Review.

PMID:
22515274
[PubMed - indexed for MEDLINE]
14.

Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.

Ray LA, Chin PF, Miotto K.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):13-22. Review.

PMID:
20201811
[PubMed - indexed for MEDLINE]
15.

The contribution of genetics to addiction therapy approaches.

Edenberg HJ, Kranzler HR.

Pharmacol Ther. 2005 Oct;108(1):86-93. Review.

PMID:
16026844
[PubMed - indexed for MEDLINE]
16.

Polymorphisms in the mu-opioid receptor gene (OPRM1) and the implications for alcohol dependence in humans.

van der Zwaluw CS, van den Wildenberg E, Wiers RW, Franke B, Buitelaar J, Scholte RH, Engels RC.

Pharmacogenomics. 2007 Oct;8(10):1427-36. Review.

PMID:
17979515
[PubMed - indexed for MEDLINE]
17.

An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants.

Ait-Daoud N, Malcolm RJ Jr, Johnson BA.

Addict Behav. 2006 Sep;31(9):1628-49. Epub 2006 Feb 10. Review.

PMID:
16472931
[PubMed - indexed for MEDLINE]
18.

Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2.

Kenna GA, McGeary JE, Swift RM.

Am J Health Syst Pharm. 2004 Nov 15;61(22):2380-8. Review.

PMID:
15581261
[PubMed - indexed for MEDLINE]
19.

Candidate gene studies of attention-deficit/hyperactivity disorder.

Faraone SV, Khan SA.

J Clin Psychiatry. 2006;67 Suppl 8:13-20. Review.

PMID:
16961425
[PubMed - indexed for MEDLINE]
20.

Efficacy and tolerability of naltrexone in the management of alcohol dependence.

Garbutt JC.

Curr Pharm Des. 2010;16(19):2091-7. Review.

PMID:
20482515
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk